Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Fertility Science and Research

Anti-Mullerian Hormone as a Surrogate Diagnostic Marker for Polycystic Ovary Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

NJNishtha JaiswalMPManju Puri

Discussion

Loading...

Member takes

Overview

Observational analysis shows AMH levels correlate with polycystic ovarian morphology in PCOS, suggesting its diagnostic potential.

Key Points

  • Increased AMH levels are associated with polycystic ovary syndrome, indicating potential diagnostic utility.
  • The study highlights the complexity of identifying standardized AMH threshold values for PCOS.
  • Variations in AMH values across different PCOS phenotypes complicate its use as a diagnostic marker.
  • AMH levels may influence treatment outcomes for infertility in women with polycystic ovary syndrome.

Cite This Study

Jaiswal et al. (2025) studied this question.

synapsesocial.com/papers/68c1b36054b1d3bfb60ea546https://doi.org/10.25259/fsr_24_2025
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1THE DIAGNOSTIC AND PROGNOSTIC ROLE OF ANTI-MÜLLERIAN HORMONE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME2025
  2. 2Anti-Mullarian Hormone As A Diagnostic Marker of Polycystic Ovary Syndrome2024 · 1 citations
  3. 3The Adjunct Role of Anti Mullerian Hormone (AMH) in Diagnosing Polycystic Ovary Syndrome2024 · 1 citations
  4. 4The relationship of antimullerian hormone with severity of clinical symptoms in polycystic ovary syndrome2025 · 3 citations
  5. 5The Relationship of Antimullerian Hormone with Severity of Clinical Symptoms in Polycystic Ovary Syndrome2024